Walvax Biotechnology Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000WN2
CNY
12.39
-0.18 (-1.43%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Walvax Biotechnology Co., Ltd. stock-summary
stock-summary
Walvax Biotechnology Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
565 Million
(Quarterly Results - Sep 2025)
Net Profit:
111 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 17,605 Million (Large Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.09%

stock-summary
Debt Equity

-0.15

stock-summary
Return on Equity

-1.57%

stock-summary
Price to Book

1.82